Generics manufacturers must “step up” to tackle antimicrobial resistance (AMR), the Access to Medicine Foundation has insisted, in a report that “systematically evaluates how a cross-section of the pharmaceutical industry is responding to the AMR threat”.
Generics manufacturers must “step up” to tackle antimicrobial resistance (AMR), the Access to Medicine Foundation has insisted, in a report that “systematically evaluates how a cross-section of the pharmaceutical industry is responding to the AMR threat”.
Entitled ‘Antimicrobial Resistance Benchmark 2018’, the report compares 30 companies, including 10 generic medicine manufacturers, eight large research-based pharmaceutical companies...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
